Beneficial ownership — 13D / 13G
87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Balyasny Asset Management L.P. | EHAB Enhabit, Inc. | 13G/A | 5.22% | Mar 31, 2026 | 6mo |
| LMR Partners LLP | PTOR Praetorian Acquisition Corp. | 13G | 6.1% | Mar 31, 2026 | 6mo |
| METEORA CAPITAL, LLC | SELXF Semilux International Ltd. | 13G/A | 7.64% | Mar 31, 2026 | 6mo |
| Kynam Capital Management, LP | CTMX CytomX Therapeutics, Inc. | 13G/A | 6.9% | Mar 31, 2026 | 6mo |
| EVENTIDE ASSET MANAGEMENT, LLC | OVID Ovid Therapeutics Inc. | 13G | 7.3% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | IMNN Imunon, Inc. | 13G/A | 9.99% | Mar 31, 2026 | 6mo |
| CVI Investments, Inc. | ATOM Atomera Inc | 13G/A | 0% | Mar 31, 2026 | 6mo |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | NCMI National CineMedia, Inc. | 13G/A | 8.48% | Mar 31, 2026 | 6mo |
| Encompass Capital Advisors LLC | AESI Atlas Energy Solutions Inc. | 13G/A | 7.36% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | BRCB Black Rock Coffee Bar, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| Westchester Capital Management, LLC | MMTX Miluna Acquisition Corp | 13G | 5.05% | Mar 31, 2026 | 6mo |
| Nantahala Capital Management, LLC | EB Eventbrite, Inc. Class A Common Stock | 13G/A | 0% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | VSTM Verastem, Inc. | 13G/A | 5.23% | Mar 31, 2026 | 6mo |
| Peter E. Haas, Jr. | LEVI Levi Strauss & Co | 13G/A | 5.5% | Mar 31, 2026 | 6mo |
| Ning Ding | ZJK ZJK Industrial Co., Ltd. | 13G/A | 59.62% | Mar 31, 2026 | 6mo |
| Innovation Endeavors III LP | EIKN Eikon Therapeutics, Inc. | 13G | 5% | Mar 31, 2026 | 6mo |
| Orbis Investment Management Limited | MICC Magnum Ice Cream Co N.V. | 13G | 5.1% | Mar 31, 2026 | 6mo |
| VAN ECK ASSOCIATES CORP | OR OR Royalties Inc. | 13G/A | 5.74% | Mar 31, 2026 | 6mo |
| JANUS HENDERSON GROUP PLC | OSIS Osi Systems Inc | 13G/A | 4.7% | Mar 31, 2026 | 6mo |
| Capitalink Ltd. | CMND Clearmind Medicine Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| MACKENZIE FINANCIAL CORP | CSIQ Canadian Solar Inc. | 13G | 6.9% | Mar 31, 2026 | 6mo |
| ROYAL BANK OF CANADA | BIP Brookfield Infrastructure Partners Inc. | 13G/A | 4.37% | Mar 31, 2026 | 6mo |
| Neos Partners, LP | FPS Forgent Power Solutions, Inc. | 13G | 67.5% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | RVTY Revvity, Inc. | 13G/A | 9% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | BJDX Bluejay Diagnostics, Inc. | 13G/A | 4.99% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | CHRN ChronoScale Holdings Corp | 13G/A | 4.99% | Mar 31, 2026 | 6mo |
| Magnetar Financial LLC | WHLR Wheeler Real Estate Investment Trust, Inc. | 13G/A | 45% | Mar 31, 2026 | 6mo |
| Caligan Partners LP | FTH Faeth Therapeutics, Inc. | 13G | 9.4% | Mar 31, 2026 | 6mo |
| Select Equity Group, L.P. | MIDD MIDDLEBY Corp | 13G/A | 3.3% | Mar 31, 2026 | 6mo |
| Portolan Capital Management, LLC | CSTL Castle Biosciences Inc | 13G/A | 4.45% | Mar 31, 2026 | 6mo |
| Orbis Investment Management Limited | RHI Robert Half Inc. | 13G | 7.5% | Mar 31, 2026 | 6mo |
| Fourthstone LLC | MNSB MainStreet Bancshares, Inc. | 13G/A | 5.22% | Mar 31, 2026 | 6mo |
| Vestal Point Capital, LP | ANRO Alto Neuroscience, Inc. | 13G/A | 6.5% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | AVNS Avanos Medical, Inc. | 13G/A | 4.3% | Mar 31, 2026 | 6mo |
| T. Rowe Price Investment Management, Inc. | AMBQ Ambiq Micro, Inc. | 13G | 6% | Mar 31, 2026 | 6mo |
| 1607 Capital Partners, LLC | GF New Germany Fund Inc | 13G/A | 6.57% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | DRI Darden Restaurants Inc | 13G/A | 6% | Mar 31, 2026 | 6mo |
| T. Rowe Price Investment Management, Inc. | VSEC Vse Corp | 13G/A | 9.7% | Mar 31, 2026 | 6mo |
| T. Rowe Price Investment Management, Inc. | BRCC BRC Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| Orbis Investment Management Limited | ICLR Icon PLC | 13G/A | 0% | Mar 31, 2026 | 6mo |
| CoinFund Management LLC | ORBS Eightco Holdings Inc. | 13G/A | 6.1% | Mar 31, 2026 | 6mo |
| Alyeska Investment Group, L.P. | DFLI Dragonfly Energy Holdings Corp. | 13G/A | 6.18% | Mar 31, 2026 | 6mo |
| VIKING GLOBAL INVESTORS LP | ADPT Adaptive Biotechnologies Corp | 13G/A | 18.8% | Mar 31, 2026 | 6mo |
| COHEN & STEERS, INC. | AKR Acadia Realty Trust | 13G/A | 12.41% | Mar 31, 2026 | 6mo |
| Point72 Asset Management, L.P. | XLO Xilio Therapeutics, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| T. Rowe Price Investment Management, Inc. | FTI TechnipFMC plc | 13G/A | 4.2% | Mar 31, 2026 | 6mo |
| Greycroft Partners II, L.P. | MNTN MNTN, Inc. | 13G/A | 6.4% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | KYNB Kyntra Bio, Inc. | 13G/A | 9.88% | Mar 31, 2026 | 6mo |
| Vestal Point Capital, LP | IMTX Immatics N.V. | 13G/A | 4.6% | Mar 31, 2026 | 6mo |
| LMR Partners LLP | SORN Soren Acquisition Corp. | 13G | 6.5% | Mar 31, 2026 | 6mo |